Valvular heart disease is rare in Parkinson's disease patients treated with pergolide

被引：0
|
作者：
Ruzicka, E.
Linkova, H.
Penicka, M.
Roth, J.
Ulmanova, O.
Novakova, L.
Havlikova, M.
机构：
[1] Charles Univ, Dept Neurol, Prague, Czech Republic
[2] Charles Univ, Dept Cardiol, Prague, Czech Republic
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2006年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：82 / 82
页数：1
相关论文
共 50 条
  • [31] Frequency of restrictive valvular heart disease in patients with Parkinson's disease treated with pergolide, an ergot-derived anti-parkinsonian drug: a case-control echocardiographic study
    Schlesinger, I
    Katz, M
    Aharon-Perez, J
    Badarny, S
    Bloch, I
    Gross, B
    Agmon, Y
    [J]. JOURNAL OF NEUROLOGY, 2005, 252 : 30 - 30
  • [32] Pergolide-induced lung disease in patients with Parkinson's disease
    Kastelik, JA
    Aziz, I
    Greenstone, MA
    Thompson, R
    Morice, AH
    [J]. RESPIRATORY MEDICINE, 2002, 96 (07) : 548 - 550
  • [33] Valvular heart disease in Parkinson's Disease patients treated with dopamine agonists: A reader-blinded monocenter echocardiography
    Junghanns, S
    Fuhrmann, J
    Simonis, G
    Oehlwein, C
    Koch, R
    Strasser, RH
    Reichmann, H
    Storch, A
    [J]. NEUROLOGY, 2006, 66 (05) : A48 - A48
  • [34] Dopamine agonists and valvular heart disease in patients with Parkinson's disease: evidence and mystery
    Yamamoto, Mitsutoshi
    Uesugi, Tadahisa
    [J]. JOURNAL OF NEUROLOGY, 2007, 254 (Suppl 5) : 74 - 78
  • [35] Assessment of valvular heart disease in patients with Parkinson's disease on ergot dopamine agonists
    Kenangil, G.
    Ozekmekci, S.
    Koldas, L.
    Sahin, T.
    Erginoz, E.
    [J]. MOVEMENT DISORDERS, 2006, 21 : S610 - S611
  • [36] Dopamine agonists and valvular heart disease in patients with Parkinson's disease: evidence and mystery
    Mitsutoshi Yamamoto
    Tadahisa Uesugi
    [J]. Journal of Neurology, 2007, 254 : 74 - 78
  • [37] Pergolide-associated valvular heart disease in Singapore
    [J]. Reactions Weekly, 2005, 1038 (1) : 4 - 4
  • [38] Valvular heart disease in patients exposed to pergolide: insights from the clinical presentation
    Krishnaswami, Ashok
    Albers, Kathleen B.
    Fross, Robin D.
    Jang, James J.
    Berkheimer, Sarah B.
    Ben, Valerie C. Kwai
    VanDenEeden, Stephen K.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (03) : 276 - 280
  • [39] The pharmacokinetics of pergolide in Parkinson's disease
    Blin, O
    [J]. CURRENT OPINION IN NEUROLOGY, 2003, 16 : S9 - S12
  • [40] Plasma homocysteine levels in pergolide-treated Parkinson disease patients
    Özkan, S
    Colak, Ö
    Kutlu, C
    Ertan, M
    Alatas, Ö
    [J]. CLINICAL NEUROPHARMACOLOGY, 2004, 27 (04) : 163 - 165
12345